These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. 9-Valent human papillomavirus vaccine: a review of the clinical development program. Luxembourg A; Moeller E Expert Rev Vaccines; 2017 Nov; 16(11):1119-1139. PubMed ID: 28956458 [TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus: optimizing opportunities for prevention. Browne S; Feemster KA Curr Opin Pediatr; 2022 Apr; 34(2):132-139. PubMed ID: 35152231 [TBL] [Abstract][Full Text] [Related]
30. HPV and HPV-associated diseases. Dunne EF; Park IU Infect Dis Clin North Am; 2013 Dec; 27(4):765-78. PubMed ID: 24275269 [TBL] [Abstract][Full Text] [Related]
31. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Hong AM; Grulich AE; Jones D; Lee CS; Garland SM; Dobbins TA; Clark JR; Harnett GB; Milross CG; O'Brien CJ; Rose BR Vaccine; 2010 Apr; 28(19):3269-72. PubMed ID: 20226244 [TBL] [Abstract][Full Text] [Related]
32. Current status of human papillomavirus vaccination. Brotherton JM; Ogilvie GS Curr Opin Oncol; 2015 Sep; 27(5):399-404. PubMed ID: 26258273 [TBL] [Abstract][Full Text] [Related]
33. The current state of therapeutic and T cell-based vaccines against human papillomaviruses. Yang A; Farmer E; Lin J; Wu TC; Hung CF Virus Res; 2017 Mar; 231():148-165. PubMed ID: 27932207 [TBL] [Abstract][Full Text] [Related]
34. HPV Vaccine Slashes Rates of Oral Infection. Cancer Discov; 2017 Jul; 7(7):OF6. PubMed ID: 28526738 [TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases. Skinner SR; Apter D; De Carvalho N; Harper DM; Konno R; Paavonen J; Romanowski B; Roteli-Martins C; Burlet N; Mihalyi A; Struyf F Expert Rev Vaccines; 2016; 15(3):367-87. PubMed ID: 26902666 [TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus-related oropharyngeal cancer in the HIV-infected population. Wang CC; Palefsky JM Oral Dis; 2016 Apr; 22 Suppl 1():98-106. PubMed ID: 27109278 [TBL] [Abstract][Full Text] [Related]
38. Beyond cervical cancer: burden of other HPV-related cancers among men and women. Chaturvedi AK J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840 [TBL] [Abstract][Full Text] [Related]
39. HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs? Takes RP; Wierzbicka M; D'Souza G; Jackowska J; Silver CE; Rodrigo JP; Dikkers FG; Olsen KD; Rinaldo A; Brakenhoff RH; Ferlito A Oral Oncol; 2015 Dec; 51(12):1057-60. PubMed ID: 26520047 [TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. Gillison ML J Adolesc Health; 2008 Oct; 43(4 Suppl):S52-60. PubMed ID: 18809146 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]